Catherine Velazquez, a US HealthTech leader, is the Director, PV Training and Quality at Ionis Pharmaceuticals, a company focused on RNA-targeted medicines. With 20+ years in drug development, Catherine drives collaboration among PV teams, ensuring adherence to regulatory and safety standards, ultimately advancing patient safety outcomes. Her expertise spans roles at Ascendis Pharma, Bristol Myers Squibb, MyoKardia, and Genentech, reflecting her deep commitment to pharmacovigilance excellence.
666 3rd Ave, 6th Floor, New York, NY 10017